Showing results (251-260 of 263) with videos related to

Sort By:
Pageof 27
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1999
Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in manS F Slovin, G Ragupathi, S Adluri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2001
Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylaseL M Butler, Y Webb, D B Agus, et al.
British Journal of Cancer|October 31, 2013
First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancerD Bianchini, A Omlin, C Pezaro, et al.
Cancer Research|November 21, 2000
Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1L C Amler, D B Agus, C LeDuc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Interferon-gamma and monoclonal antibody 131I-labeled CC49: outcomes in patients with androgen-independent prostate cancerS F Slovin, H I Scher, C R Divgi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Etoposide in malignant pleural mesothelioma: two phase II trials of the EORTC Lung Cancer Cooperative GroupT Sahmoud, P E Postmus, C van Pottelsberghe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2015
A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxelK N Chi, T Kheoh, C J Ryan, et al.
European Journal of Cancer (Oxford, England : 1990)|April 24, 2021
Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancerH I Scher, A J Armstrong, J D Schonhoft, et al.
Anti-Cancer Drugs|March 23, 2001
D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group StudyF Duffaud, M E van der Burg, M Namer, et al.
Prostate Cancer and Prostatic Diseases|June 28, 2017
Periprostatic adipose inflammation is associated with high-grade prostate cancerA Gucalp, N M Iyengar, X K Zhou, et al.
Pageof 27